Skip to main content
. 2018 Aug 24;6(4):291–296. doi: 10.1016/j.esxm.2018.07.001

Figure 1.

Figure 1

Study protocol. Men with erectile dysfunction received a placebo for 30 days or the active treatment for another 30 days without washout before crossover. Patients continued on-demand use of PDE5i. PDE5i = phosphodiesterase type 5 inhibitor.